1. Home
  2. NRXP vs GAME Comparison

NRXP vs GAME Comparison

Compare NRXP & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • GAME
  • Stock Information
  • Founded
  • NRXP 2015
  • GAME 2011
  • Country
  • NRXP United States
  • GAME United States
  • Employees
  • NRXP N/A
  • GAME N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • GAME
  • Sector
  • NRXP Health Care
  • GAME
  • Exchange
  • NRXP Nasdaq
  • GAME Nasdaq
  • Market Cap
  • NRXP 32.6M
  • GAME 27.2M
  • IPO Year
  • NRXP N/A
  • GAME 2009
  • Fundamental
  • Price
  • NRXP $3.39
  • GAME $1.41
  • Analyst Decision
  • NRXP Strong Buy
  • GAME Strong Buy
  • Analyst Count
  • NRXP 4
  • GAME 3
  • Target Price
  • NRXP $28.50
  • GAME $3.67
  • AVG Volume (30 Days)
  • NRXP 284.1K
  • GAME 529.3K
  • Earning Date
  • NRXP 08-13-2025
  • GAME 08-13-2025
  • Dividend Yield
  • NRXP N/A
  • GAME N/A
  • EPS Growth
  • NRXP N/A
  • GAME N/A
  • EPS
  • NRXP N/A
  • GAME N/A
  • Revenue
  • NRXP N/A
  • GAME $99,579,536.00
  • Revenue This Year
  • NRXP N/A
  • GAME $6.08
  • Revenue Next Year
  • NRXP N/A
  • GAME $21.94
  • P/E Ratio
  • NRXP N/A
  • GAME N/A
  • Revenue Growth
  • NRXP N/A
  • GAME 77.06
  • 52 Week Low
  • NRXP $1.10
  • GAME $0.50
  • 52 Week High
  • NRXP $6.01
  • GAME $1.37
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 59.13
  • GAME 66.10
  • Support Level
  • NRXP $2.90
  • GAME $0.73
  • Resistance Level
  • NRXP $3.53
  • GAME $0.97
  • Average True Range (ATR)
  • NRXP 0.20
  • GAME 0.07
  • MACD
  • NRXP -0.03
  • GAME 0.02
  • Stochastic Oscillator
  • NRXP 79.37
  • GAME 85.69

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.

Share on Social Networks: